INCR INC Research Holdings Inc

Syneos Health Bolsters Communications Leadership Team

Syneos Health Bolsters Communications Leadership Team

Tim Pantello Appointed to Lead One of the World’s Largest Healthcare-Only Agency Portfolios

Joined by a Trio of Senior Hires with Deep Strategic, Therapeutic, Marketing and Technology Expertise

MORRISVILLE, N.C., July 07, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced new top talent joining the Company’s Communications business. Designed to deliver insights-driven integrated communications, the healthcare-only agency portfolio spans advertising, public relations, medical communications, managed markets, omnichannel, digital, naming, and branding. Syneos Health Communications consistently appears on top agency ranking lists and recently earned a top-three spot on .

Purpose built to be a healthcare company delivering exceptional communications, as opposed to a communications company doing healthcare, the Syneos Health Communications business offers unsurpassed breadth, scale, and the ability to go deep into a community or disease space to translate insights into impact. 

Tim Pantello has taken the helm to lead the integrated portfolio business, serving as President of Communications. A versatile executive with nearly 25 years of experience across strategy, marketing, and technology, his digitally native leadership style is ideal for grooming the next generation of communications experts. Prior to Syneos Health, Pantello was a managing director at PricewaterhouseCoopers (PwC), leading multiple offerings within the Health Industry Advisory Group related to wearable data, patient intelligence and predictive behaviors and analytics. He reports to Michelle Keefe, President, Syneos Health Commercial Solutions.

“Tim is further embedding strategic insights, behavioral science, and digital transformation across our communications business – strengthening foundational capabilities that are proving mission critical to our customers during this transformative time,” said Keefe. “Now more than ever, customers are relying on strategic communications to navigate unchartered challenges. Tim’s expertise, combining consulting methodologies and pioneering communications practices, is getting our customers faster to what matters.”

Since joining in January, Pantello has focused on infusing data, behavioral science, and omnichannel experiences to enhance customer value. Bolstering senior leadership, which includes Syneos Health veterans Sonja Foster-Storch and Lisa Stockman, Pantello has added the following talent:

JD Cassidy, President of Advertising

Cassidy is leading Syneos Health Communications’ North America advertising portfolio, with dedicated responsibility for GSW NY. He joins from Saatchi & Saatchi Wellness, where he served as President, simultaneously growing revenue and employee engagement. He has worked on multiple brands and therapeutic categories and has omnichannel expertise across patients, providers, and payers. Prior to Saatchi & Saatchi, he was in global leadership roles for Publicis Health, D.i.D, and Digitas Health.

Maria Tender, Head of Strategy

Tender is leading strategy and planning for Syneos Health Communications. She joins from DDB where, for more than two decades, she led strategy and planning and built the healthcare strategy group. At DDB, she oversaw new business development across a range of sectors, including large pharmaceutical companies across numerous therapeutic areas.  Internally, she developed best-in-class training and development.

Ian Dorrian, President of EU Communications

Dorrian is leading Communications in Europe and brings more than 20 years of agency experience spanning independent firms, major holding companies, including Omnicom, regional and global roles, and has deep therapeutic expertise in oncology and rare disease. Prior to his agency experience, he was in the pharmaceutical industry for 10 years, gaining experience in medical affairs, field sales, and operational and strategic marketing roles.

“Our entire model is about acceleration and our Communications organization is built on agility and speed. Beyond big creative and standalone strategy, scale, clinical and scientific depth, skill and a pure-play focus on health matters,” said Pantello in the Medical Marketing & Media Agency 100 profile. “Our ability to bring multiple disciplines together across the product lifecycle – truly understanding clinical development and pulling it through communications strategies – is unique within the industry.”

The portfolio of communications agencies at Syneos Health includes GSW, Navicor, Chandler Chicco Agency, Biosector 2, Chamberlain Healthcare Communications, Cadent Medical Communications, Managed Markets Communications and Addison Whitney, among others. Unique cross-functional teams – like Syneos Health Value & Access – provide customers access to broad Commercial expertise and Clinical development insights.

Syneos Health agencies work in scalable, purpose-built teams that partner across disciplines and geographies to accelerate brand performance.

About Syneos Health

Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Our Company bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life®, visit .

Syneos Health Investor Relations Contact:Syneos Health Press/Media Contact:
Ronnie Speight Danielle DeForge
Senior Vice President, Investor RelationsExecutive Director, External Communications
 
  

 

EN
07/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on INC Research Holdings Inc

 PRESS RELEASE

Syneos Health Closes Transaction with Private Investment Firms

Syneos Health Closes Transaction with Private Investment Firms Transaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma Customers MORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced the completion of its acquisition by a consortium of private investment firm affiliates composed of Elliott Investment Management L.P., Patient Square Capital and Veritas Capital. As a result of the...

 PRESS RELEASE

Syneos Health Names Terttu Haring President, Clinical Sites & Patients

Syneos Health Names Terttu Haring President, Clinical Sites & Patients Industry Veteran to Play Critical Role in Leading Global Clinical Operations, Cultivating Site Relationships, Empowering Patients and Shaping Innovative Clinical Trial Solutions MORRISVILLE, N.C., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, has announced the appointment of Terttu Haring, MD, as President, Clinical Sites & Patients. With nearly 30 years of experience, Dr. Haring will lead the global clinical operations organizat...

 PRESS RELEASE

Syneos Health and Oracle to Expand Relationship to Accelerate Patient ...

Syneos Health and Oracle to Expand Relationship to Accelerate Patient Recruitment & Advance Health Equity MORRISVILLE, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic collaboration that will expand its relationship with Oracle. Using the Oracle Cerner Learning Health Network (LHN) and elements of Oracle’s suite of study startup solutions, the companies seek to help reduce the time it takes to recruit patients for clinical studies and increase the diversity of patient pop...

 PRESS RELEASE

Syneos Health, Inc. and Star Parent, Inc. Announce Proposed $1.70 Bill...

Syneos Health, Inc. and Star Parent, Inc. Announce Proposed $1.70 Billion Offering of Senior Secured Notes MORRISVILLE, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Star Parent, Inc. (the “Issuer” or the “Company”) and Syneos Health, Inc. (“Syneos Health”), announced today that, subject to market conditions and other factors, the Issuer intends to offer $1,700,000,000 aggregate principal amount of Senior Secured Notes due 2030 (the “Notes”). The Issuer intends to use the proceeds from the offering together with other financing sources to fund the previously announced acquisition of Syneos Hea...

 PRESS RELEASE

Syneos Health Stockholders Approve Agreement with Private Investment C...

Syneos Health Stockholders Approve Agreement with Private Investment Consortium MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced that the Company’s stockholders approved an agreement to take the Company private through an acquisition by a consortium of private investment firm affiliates comprised of Elliott Investment Management L.P., Patient Square Capital, and Veritas Capital at a special meeting of stockholders held earlier toda...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch